Docoh
Loading...

NMTR 9 Meters Biopharma

Employees

Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM



The Company held its 2021 annual meeting of stockholders on June 22, 2021.




As of May 4, 2021, the record date for the annual meeting, there were 251,329,896 shares of common stock issued and outstanding.




At the Meeting, the stockholders approved the following three proposals and cast their votes as follows:




1. To elect one Class III director to serve a three-year term expiring at the 2024 annual meeting of stockholders and until such director’s successor is elected and qualified, or until his earlier death, resignation, or removal, based on the following votes:

Director:

Votes For
Votes WithheldBroker Non-Votes
Mark Sirgo99,884,2885,392,28657,784,618





2. To approve the Charter Share Issuance Amendment:

Votes For

Votes Against
Votes AbstainedBroker Non-Votes
140,897,74020,453,5371,709,915--





3. To ratify the selection of Mayer Hoffman McCann, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2021:

Votes For

Votes Against
Votes AbstainedBroker Non-Votes
159,449,1631,807,5431,804,486--